How does the pharmaceutical disclosure code affect health care providers?

 

January 29th  2015 –  Hilton, Rotterdam – 9.30-13.15

ABOUT THE EVENT – AGENDA – REPORT – DOWNLOADS & VIDEO 

Agenda:

 9.30  Registration and welcome coffee
 10.00  A view from Brussels – Financial Disclosure and Public Policy

  • Lode Wigersma, Former Director, Royal Dutch Medical Association
  • Carin Smand, Managing Director, European Hematology Association
  • Anne Britta Haas, Counsel, Clifford Chance
  • Bernard Maillet, VP eHealth, CPME
  • Cees Smit, Patient advocate and policy advisor, EGAN

moderator: Duane Schulthess, Managing Director, Vital Transformation

 11.20  Coffee Break
 11.30  Going Live: Implementing Disclosure in the Member States

  • Romuald Krajewski, Professor Neurosurgery, Cancer Center M. Sklodowska-Curie Memorial Hospital, Warsaw
  • Krzysztof Kałużny, Project Manager Disclosure Code, INFARMA, Poland
  • Holger Diener, Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry, Germany
  • Andy Powrie-Smith, Communications Director, EFPIA

moderator: Duane Schulthess, Managing Director, Vital Transformation

 12.45  Networking Lunch
 13.15  End of the event

SPACER

 

 

This event is supported by:

white
 nefarma_logo

 

SPACERSPACER